Holger Wesche - 11 Nov 2021 Form 4 Insider Report for Harpoon Therapeutics, Inc.

Role
Chief Scientific Officer
Signature
/s/ Holger Wesche by Georgia Erbez, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
11 Nov 2021
Net transactions value
$0
Form type
4
Filing time
15 Nov 2021, 15:04:23 UTC
Previous filing
06 Jul 2021
Next filing
01 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HARP Employee Stock Option (right to buy) Award $0 +135,000 $0.000000 135,000 11 Nov 2021 Common Stock 135,000 $7.73 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fifty percent of the stock option shall be fully vested and exercisable on the first anniversary of the vesting commencement date, November 11, 2022, and thereafter twenty-five percent of the stock option shall vest on each May 11, 2023, and November 11, 2023.